Clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of juvenile inflammation of the joints requires individualized development of treatment programs, usually including drug therapy, rehabilitation, rehabilitation, periodic multi-dimensional management, etc. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in disease. The platform serves the China International Medical Service System, which combines domestic and foreign authoritative teams of experts in the field of autoimmunity and rheumatic immunity, to provide the following services to patients: 1. Remote pre-diagnosis: Pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2.
Interviews in China: Arrangements with authoritative experts for face-to-face diagnosis, development of personalized treatment programs; 3. Full-service: One-stop services: medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: Establishment of chronic disease management files, continuous monitoring of disease changes and treatment effects.
Support for remote pre-diagnosis, visiting interviews, full translation and escort.